In endometrial mesenchymal stromal cells obtained from women with stage III or IV EM, quinagolide induced a reduction of endothelial invasion and differentiation through the AKT signalling pathway, negatively regulating AKT and its phosphorylation [51]. The gene discussed is AKT1; the disease is erythema multiforme.